What Happened?
Boston, MA-based Axial-Biotherapeutics Appointed David Donabedian as Chief Executive Officer, Co founder and Director
About the Company
Axial Biotherapeutics is a biopharmaceutical company harnessing the link between the human gut microbiome and Central Nervous System to develop a new class of therapeutics to improve the quality of life for people with CNS diseases and disorders
About the Person
David Donabedian is Chief Executive Officer, Co founder and Director at Axial Biotherapeutics. Previously, David held various senior HR leadership roles in the industry.
Info Source
News
Short Profile